Seres Therapeutics Inc.
0.78
0.01 (1.79%)
At close: Jan 15, 2025, 3:57 PM
0.78
-0.14%
After-hours Jan 15, 2025, 04:00 PM EST

Seres Therapeutics Inc. Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for MCRB stock have an median target of 5.62, with a low estimate of 1.25 and a high estimate of 10. The median target predicts an increase of 620.51% from the current stock price of 0.78.

Analyst Consensus: Buy
Target Low Average Median High
Price $1.25 $5.62 $5.62 $10
Change 60.26% 620.51% 620.51% 1182.05%

AI Analyst Report

Chardan Capital has reaffirmed a Buy rating on Ser... Unlock content with Pro Subscription

Updated Nov 13, 2024

Rating May 24Jun 24Aug 24Sep 24Oct 24Nov 24
Strong Buy 000000
Buy 212102
Hold 010000
Sell 000010
Strong Sell 000000
Total 2 2 2 1 1 2

Financial Forecast this Year

Revenue This Year
31.00M
from 126.33M
Increased by -75.5%
Revenue Next Year
33.08M
from 31.00M
Increased by 6.7%
EPS This Year
-0.12
from -0.89
Increased by 86.5%
EPS Next Year
-0.33
from -0.12
Increased by -175%